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Abstract 
The need to search for biomaterials that can promote tissue regeneration and easy to replicate and 
manufacture is a major driving force for research and development in the area of reconstructive surgery 
and regenerative medicine. It is of great importance to otolaryngologists to find alternate solutions that 
require harvesting large amounts of autologous cartilage in patients needing cartilage grafts. Due to its 
very limited self-regeneration capacity, cartilage repair and reconstruction is extremely challenging. 
Microtia is a congenital condition of abnormal development of the outer and/ or the middle ear and can 
range from mild to complete absence of the ear. Current treatment methods such as autologous, 
alloplastic and prosthetic reconstruction have limitations such as donor site morbidity, long-term 
complications and implant failure. 3D printing is an exciting solution to address the challenges of microtia 
and create customised implants. The ability to deposit cells and biomaterials in a controlled and precise 
manner, allows the fabrication of implants with complex internal architecture and functional properties 
not achievable through traditional manufacturing methods. Despite the ability to mimic native properties 
and structure of tissue, 3D printed constructs using pristine inks lack the structural integrity and adequate 
mechanical properties for use in vivo or handling. These requirements highlight the importance of ink 
development and selection, which is a continuing challenge in the bioprinting process. This review will 
address the current treatment options for patients with microtia and the potential of 3D bioprinting in area 
of auricular cartilage regeneration. In particular, the use of hybrid printing to better mimic the practical 
and functional requirements of an ear scaffold will be discussed. 
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Abstract 
The need to search for biomaterials that can promote tissue regeneration and easy to replicate 
and manufacture is a major driving force for research and development in the area of 
reconstructive surgery and regenerative medicine. It is of great importance to otolaryngologists 
to find alternate solutions that require harvesting large amounts of autologous cartilage in 
patients needing cartilage grafts. Due to its very limited self-regeneration capacity, cartilage 
repair and reconstruction is extremely challenging. Microtia is a congenital condition of 
abnormal development of the outer and/ or the middle ear and can range from mild to complete 
absence of the ear. Current treatment methods such as autologous, alloplastic and prosthetic 
reconstruction have limitations such as donor site morbidity, long-term complications and 
implant failure. 3D printing is an exciting solution to address the challenges of microtia and 
create customised implants. The ability to deposit cells and biomaterials in a controlled and 
precise manner, allows the fabrication of implants with complex internal architecture and 
functional properties not achievable through traditional manufacturing methods. Despite the 
ability to mimic native properties and structure of tissue, 3D printed constructs using pristine 
inks lack the structural integrity and adequate mechanical properties for use in vivo or handling. 
These requirements highlight the importance of ink development and selection, which is a 
continuing challenge in the bioprinting process. This review will address the current treatment 
options for patients with microtia and the potential of 3D bioprinting in area of auricular 
cartilage regeneration. In particular, the use of hybrid printing to better mimic the practical and 
functional requirements of an ear scaffold will be discussed.  
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1. Introduction 
In Otorhinolaryngology, cartilage is of particular interest because of its presence in multiple 
structures in the ear (pinna), nose (septum and alar) and throat (larynx and trachea). Further it 
is used as graft material in surgical interventions from cerebrospinal fluid (CSF) leak repairs 
[1], Ossicular Chain Reconstruction (OCRs) [2], Microtia reconstruction [3] and 
Laryngotracheal reconstructions [4]. It is therefore a tissue of great importance to 
Otolaryngologists. Due to its very limited self-regeneration capacity, cartilage repair and 
reconstruction is extremely challenging.  
Microtia is a congenital condition where there is an abnormal development of the outer and/ or 
the middle ear and can range from mild to complete absence of the ear [5]. Overall, the 
incidence of microtia is about 1-4 per 10,000 births, but can vary between countries. Of these, 
10% of patients will present with bilateral diseases [6]. Treatment is demanding with long hours 
and numerous stages of surgery. In addition, complications present in the donor site and the 
receiver site includes failure, scarring, and most of all, donor site morbidity.    
Bioprinting is an exciting solution to address the challenges of microtia and create customised 
implants, but research in this area around the world has not yet translated into meaningful 
results of clinical relevance. In this review, the various treatment options for microtia will be 
discussed and the potential of 3D bioprinting in the area of cartilage regeneration will be 
highlighted. In particular, the use of 3D printing to satisfy the mechanical, biological and 
printing requirement of the entire construct will be discussed. The range of printable 
biomaterials and cell sources relevant to auricular reconstruction will also be reviewed.   
2. Pathology 
Ear deformity can have a significant social and psychological impact on the individual. It can 
occur as a result of trauma (67,000 patients have ear deformities caused by burns/year in the 
US), burns, cancer (malignant lesion of the ear account for approximately 13% of all head and 
neck melanomas), scars, or congenital abnormalities [7]. 
 
The external ear consists of the auricle and the external ear canal. Microtia is a developmental 
malformation of the external ear, characterised by a small abnormally shaped auricle or pinna. 
The disorder can be either a genetic or environmental factor, an isolated condition or part of a 
spectrum of abnormalities. Several possibilities for the cause is suggested but still poorly 
understood. These include vertebrae abnormalities [8], medications [9, 10], genetic disorders 
[11], and even illness during pregnancy [12]. There are two forms of microtia, unilateral or 
bilateral. Unilateral occurs in 79-93% of the cases and the right side is more often affected [6, 
13]. In individuals that have unilateral microtia, the speech and language developments are 
normal, due to the normal functioning collateral ear. Figure 1 presents different grades of 
microtia, ranging from mild structural abnormalities to complete loss of the ear. The 
classification system was first developed by Hermann Marx in 1926 and was later modified by 
Meurman [5]. Grade I refers to individuals having all features of the normal auricle, but the 
pinna is smaller than normal. In grade II, only some features are present. Grade III is most 
commonly seen in patients that undergo ear reconstruction as only a portion of soft tissue is 
present, resulting in a peanut-shaped ear. In grade IV (or anotia), there is no external ear and 
auditory canal. This is often associated with hearing loss and requires treatment for hearing 
impairment and surgical ear reconstruction. Another classification also in use separates 
microtic ear deformities into lobular and conchal types [3, 11].  
 
 
Figure 1 Ear classified by grades I to IV and as lobular or conchal types 
 
3. Treatment options for microtia 
3.1 Autologous reconstruction 
Autologous reconstruction remains the first treatment option for patients with classical microtia 
and no prior surgery, as this approach leaves options open for allografts or Osseo integrated 
prosthesis if it fails. The reconstruction of microtia can be broken down into 2 main steps. First 
is to mimic the contours of the normal ear by “sculpturing” a framework from autogenous 
cartilage. The second step is the coverage of the framework with skin grafts or adjacent skin 
[3]. It has been suggested that reconstruction of the ear can begin as early as 5 to 6 years of age 
to prevent social and psychological stress from peers at school. Many have reported the benefits 
of delaying the surgery until 9 to 10 years old [14-17] , and when the chest circumference has 
grown to at least 60cm so that there is sufficient cartilage for harvesting [5]. The benefits of 
autologous reconstruction include long-term stability, limited rejection and minimises the risk 
of extrusion of the implant. The grafts also possess the potential to grow with the patient as 
they mature [18]. 
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3.1.1 Techniques 
The anatomy of the ear consists of eminences and depressions, shown in Figure 2.  A significant 
breakthrough in the field of ear reconstruction was introduced by Tanzer in the late 1950s [19]. 
It involves a 4-stage reconstruction process from carving a solid block of autogenous costal 
cartilage. Costal cartilage (rib cartilage) has proven to be the source of cartilage that provided 
an adequate quantity and integrity [20, 21]. Modifications of this technique are still regarded 
as the 'gold standard' for patients with microtia and other ear deformities [22]. Brent mastered 
a three-stage reconstruction building from this technique, while Nagata and Firmin further 
refined the technique to allow early positioning of the lobular segment of the vestige and 
constructing in 2 stages [14, 17]. A summary of the different techniques to reconstruct microtia 






















Table 1.Summary of techniques to reconstruct microtia 
Surgeon Ages Stages Technique 
    
Tanzer [19, 24] 6-7+ 4 I. Rotation of Lobule 
II. Fabrication of the costal cartilage 
framework 
III. Elevation of the framework 
IV. Construction of tragus and conchal 
cavity 
Brent[21] 6-8+ 3 I. Fabrication of the costal cartilage 
framework 
II. Lobule transposition 
III. Elevation of framework 
IV. Tragus reconstruction 
Nagata [14-16, 25, 26] 10+ 2 I. Fabrication of the costal cartilage 
framework. Include tragus, conchal 
cavity and lobule 
II. Elevation of the framework after 4 
months. Covered with skin graft 
Park [27] 10+ 3 I. Insertion of tissue expander. 
Continues for 5 months 
II. Fabrication of costal cartilage 
framework and inserted between 
skin flaps 
III. Skin incisions to create tragus, 
conchal and external auditory 
canal 
Firmin [17] 9-10+ 2 I. Framework placed under skin 
pocket for 6 months 
II. Sulcus created using additional 
cartilage graft for projection 
 
3.1.2 Limitations of autologous reconstruction 
Donor site morbidity is a constant concern reported in several case studies because of the need 
to harvest multiple sections of the costal rib, mainly 6th, 7th and 8th, to make just the auricular 
body framework and 9th for the helical component [28]. Besides pain, there is also a potential 
for lung collapse or chest wall depression.  As the costal ribs are harvested, the stability of the 
anterior ends of the rib against the sternum is much less and the rib bends inwards through 
growth and negative respiratory pressure [29]. This is some of the reasons why several studies 
prefer Brent’s technique over Nagata’s as it requires less cartilage, but also delaying the surgery 
till the patient is much older [23, 30]. 
  
A method to prevent chest wall deformity include using cartilage from cadavers (allogeneic 
reconstruction). The use of cadaver cartilage has also shown to be a promising alternative to 
autologous cartilage. Studies conducted by Go et al. [31] on 42 patients demonstrated that 
patients having their empty perichondrial space filled with irradiated cadaver cartilage after 
harvesting are equally effective in preventing chest wall depression as ones filled with 
autologous cartilage. Another study used irradiated homograft costal cartilage directly to 
perform auricular reconstruction on 19 patients. The reports showed no short-term and long-
term complications after 36 months and 90% of subjects were satisfied with the outcome [32]. 
Limitations for using cadaver cartilage is most certainly the possibility of graft infection and 
surgical cost [31]. Nevertheless, this approach can eliminate the need for graft harvesting, 
hence donor site morbidity.  
 
Aesthetically, some of the limitations include cartilage resorption and scarring. Costal cartilage 
is still reported as the best substitute for auricular reconstruction [20, 21]. However, the costal 
cartilage has no elastic fibres and lacks the flexibility of a normal ear, giving it an overall rigid 
appearance [28, 33]. There are also reports on calcification in using costal cartilages for 
auricular reconstruction [34]. Finally, it also resorbs rapidly and as the skin contracts heavily 
during the healing process, scarring and skin necrosis can occur. Table 2 summarises the types 
of complications after costal cartilage rib harvesting and are usually indicators of success and 











Table 2. Percentage of complications after autologous auricular reconstruction 
Complications Incidence Total number of 
patients in study 
Reference 
Donor-site morbidity    
Infection 5 (19%) 27 [11] 
Chest deformities 5 (6%) 88 [35] 
3(7%) 42 [36] 
Thoracic scoliosis 4(25%) 16 [29] 
Cartilage Resorption 3 (11%) 27 [11] 
Pleural Tear 1 (4%) 27 [11] 
 
19 (22%) 88 [35] 
Necrosis 1 (4%) 27 [11] 
 
1 (0.3%) 350 [37] 
Atelectasis 1 (7%) 15 [3] 
 
7 (8%) 88 [35] 
    
Aesthetics    
Under/oversized 
framework 
3 (11%) 27 [11] 
Scarring 3 (20%) 15 [3] 
 
12 (14%) 88 [35] 
 
21 (6%) 350 [37] 
Exposure 2 (5%) 40 [3] 
 
4 (1.2%) 350 [37] 
 
 
3.2 Alloplastic reconstruction 
Alloplastic reconstruction can offer several advantages over autologous reconstruction, such 
as avoiding donor site morbidity, shorter surgery time, improved size and contour matching, 
and less demanding learning curve for the surgeon. The ideal shaped ear can be produced in 
advance and several materials such as nylon mesh, silicone, polyethylene, acrylic and polyester 
have been introduced over the years as potential candidates [20, 38]. As with all other foreign 
body implants, there are potential risks associated with this method, such as infection, necrosis 
and implant exposure. Another difficulty in manufacturing alloplastic implants is to 
accommodate all the variations in size and shape required to mimic the patient’s normal ear. 
The implants are not customised and often the surgeon would have to compromise for one that 
is the closest match. This is not the case in autologous reconstruction where the surgeons can 
carve the cartilage to obtain what is required. Interestingly, around 10% of patients still have 
either a under or oversized framework, showing the complexity in shaping the harvested 
cartilage and matching the contralateral ear either by eye or imaging technologies [11]. 
Silicone framework for auricular reconstruction was first introduced by Cronin in the 1960s 
[39, 40] and later by Ohmori et al. [41, 42]. These materials showed good initial results, with 
flexibility mimicking the native cartilage, excellent aesthetic outcomes and donor site 
morbidity was not a concern. Follow up results however, found that implant exposure was a 
real concern and minor trauma or abrasion can cause implant failure.  
Polyethylene (PE) was first described for use as a framework in auricular reconstruction by 
Berghaus in 1983[43]. It is a non-reactive material that is available in high-density porous 
configurations with sizes of around 100-200µm. The porosity provides good anchorage for 
tissues compared to the smooth silicone as described by Cronin, thus allowing vascular and 
soft tissue in-growth [38]. The current commercially available implant, Medpor® (Porex 
Surgical Inc, Stryker, GA), is a porous and flexible polyethylene framework pioneered by John 
Reinisch that comes in two parts, a helical rim and an ear base, allowing better sizing and 
positioning [44]. Despite improvements to operative techniques, the majority of complications 
reported are still a result of framework protrusions and implant exposures rather than infection. 
Reinisch et al [45] reported the largest series of reconstruction using PE framework on 786 ears 
and reported an exposure rate of 7% with no major infection during a 12 year follow up. Other 
studies with follow-ups up to 11 years have also reported implant exposure being the most 
common issue [46, 47]. Long-term studies are still required to assess the implant performance 
over a lifetime, but early results have allowed Medpor® to become the most favourable 
alloplastic material for surgeons when performing a total ear reconstruction. Since Medpor® 
is relatively infection resistant; exposures can be managed quite effectively through complete 
flap coverage [48]. By not having to wait for cartilage to grow and mature, reconstruction can 
be done before the child enters school [49]. In addition, ear reconstruction can  performed at 
the same time as canal atresia (absence of an ear canal) surgery allowing children to have 
completely functional and aesthetically good looking ears as early as three to four years of age  
[38]. 
 
3.3 Prosthetic reconstruction 
Prosthetic reconstruction is a cost effective method to cover areas of defect for patients who 
are unable or in need to postpone surgical reconstruction. Surgeons would usually consider an 
auricular prosthesis in situations such as [44, 50]: 
1) Traumatic loss of the auricle or surrounding tissue 
2) Failed autologous reconstruction 
3) Underlying medical conditions  
4) Age 
5) Following tumour resection with possibility of recurrence 
6) Inability to undergo multiple surgeries 
The alloplastic ear is generally made from silicone and created as a mirrored contralateral ear 
through solution casting or more recently, additive manufacturing [51, 52]. There are various 
methods of attaching an auricular prosthesis to the skin, by either adhesives or an osseo-
integrated approach [53-55]. With adhesives, no surgery is needed and there is lower possibility 
of infections and inflammations around the skin. However, long-term contact with adhesives 
may result in allergic contact dermatitis and are especially difficult for patients who have 
limited vision to accurately put on. The latter approach allows the patient to accurately wear 
the prosthesis without a mirror and can withstand larger mechanical load during activities [56]. 
The concept of osseo-integration as reported by Branemark in the 1960s could be considered 
as one of the most significant advances in prosthetic surgery over the past 20 years [50, 57-59]. 
Using titanium screws as bone anchored fixtures, these implants can be connected to load 
bearing prosthetics with high success rates [54, 55, 60, 61]. The bone implants are intended to 
last a lifetime and prosthesis can be replaced every 2 to 5 years depending on wear [60]. 
 
 
4. 3D bioprinting 
3D printing have become increasingly popular in reconstructive surgery as this technology 
enables fabrication of patient-specific models for pre-operative planning, surgical guides, 
education purposes or implants. Computed tomography (CT) and magnetic resonance imaging 
(MRI) can be used to provide information regarding tissue geometries and the function at 
cellular level of the tissue [62, 63]. These raw data are then converted into a computer-aided 
design (CAD) model, which are often used as a stereolithography (STL) file. STL files can be 
imported into the 3D printer by slicing them into thin horizontal 2D layers, containing exact 
geometrical information of the 3D model. The slicing thickness of the layers and filament 
spacing is referred to as the “resolution” of a printer and depends on the ink and the nozzle tip 
of the syringe [62-64]. Finally, the accurate 3D-printed model is then built bottom-up layer by 
layer from the 2D slices. 
Bioprinting combines the technologies of 3D printing and molecular biology. It enables 
geometrically precise scaffolds to be fabricated easily and to act as a platform for living cells 
to grow and mature either in vitro or in vivo. Eventually the scaffold will degrade over time 
leaving native functional tissue in the predetermined shape, arrangement and location. 
Furthermore, the ability to control the delivery of “bioink” facilitates accurate and 
homogeneous distribution of cells in the scaffold. This is particularly beneficial in fabricating 
scaffolds for cartilage repair when the turnover of cartilage is very slow and nutrient transfer 
relies heavily on diffusion. A study conducted by Leverson et al. [65, 66] noted that non-
uniform distribution of cells led to overcrowding on the scaffold surface and that a thorough 
distribution of cells within the structure plays a vital part in extracellular matrix (ECM) 
production. The internal architecture could also be important in chondrogenesis and 
vascularisation, which could be incorporated into the print design to induce specific biological 
responses, such as vascular loops [67]. Tissue maturation and specific tissue matrix deposition 
are also found to be related to matrix stiffness and porosity, both of which can be easily 
controlled by printing parameters[68]. 
 
4.1 Types of Biofabrication techniques 
There are two 3D bioprinting techniques widely adopted in scaffold fabrication for cartilage 
regeneration: inkjet based printing and extrusion based printing systems (Figure 3). Inkjet 
printing operates on either thermal or piezoelectric actuators, which produce pressure pulses to 
form ink droplets (Figure 3a). The electrical heater uses air-pressure for the pulses to form 
droplets from the nozzle tip [63]. Both techniques are non-contact processes and are well 
known for the fast printing speed and high accuracy. Risk associated with fast printing speeds 
and small diameter sized nozzles are tip clogging, preventing the use of high viscosity inks and 
high cell densities in this method [62] 
 
Figure 3 Bioprinting systems A) ink-jet based printing and; B) extrusion-based printing 
techniques  
 
Extrusion printers on the other hand deposit the ink into a continuous filament rather than micro 
droplets by a pneumatic air-pressure or mechanical plunger based delivery system.  A 
minimum filament diameter of ~100µm results in structures with lower resolution compared 
to the above-mentioned techniques (Figure 3b). This fabrication technique however, is ideal 
for high viscosity inks and allows the printing of cell-laden hydrogels carrying high cell-density 
[62, 63, 69]. The advantage of extrusion-based printer towards cell viability after the printing 
process is studied by Park et al.[69]. They were able to prove that cells encapsulated in the 
hydrogel showed higher cell viability and attachment to the synthetic framework than cells 





4.2 Hybrid extrusion printing 
Biofabrication of the ear cartilage for example, requires a scaffold that matches the shape of 
the contralateral ear and is able to incorporate autologous chondrocytes or stem cells. It also 
needs to be strong enough to withstand contractive forces of the skin and natural bending, as 
well as degrading slowly for neo-cartilage formation. These requirements highlight the 
importance of ink development and selection, a component most challenging in the bioprinting 
process as it should satisfy both the biological needs of cell, but also the physical and 
mechanical needs of the printing process itself [70] 
 
Hybrid printing, which is the printing of constructs using one or more inks, has been explored 
as a promising strategy for engineering tissue constructs where simply one type of bioink 
cannot satisfy the mechanical, biological and printing requirement of the entire construct. The 
core element of hybrid printing involves co-deposition of two or more elements in a spatial 
controlled manner. For instance, one structure could be cell-free, providing structural integrity 
and mechanical stability of the 3D printed construct, while the other being cell-laden, provides 
the conductive environment enabling cell growth and differentiation. An example of a hybrid 
printing process is where polycaprolactone (PCL) is used as a structural material and printed 
in between chondrocyte-impregnated alginate strands [71]. In most instances, constructs with 
complex shapes are in need of a sacrificial material to account for angulation and orientation. 
 
The combination of a synthetic polymer as a framework and a cell-laden hydrogel enable the 
possibility to fabricate cartilage-like tissues as a 3D printed construct. This method is a 
promising alternative to single material inks for the reconstruction of the auricle and to produce 
patient-specific, large-volume tissues [28, 69, 72-74]. The final 3D printed construct can be 
divided into three main components as shown in Figure 4: 1) sacrificial material, 2) structural 
framework, and 3) cell supporting material. Each component has specific requirements 




Figure 4 Hybrid printing steps: A) Bioprinting a sacrificial material; B) addition of structural 
support for mechanical integrity; C) printing cell supporting material on top or in between 
strands; D) removal of sacrificial material to obtain final scaffold  
 
4.2.1 Sacrificial materials 
'Sacrificial materials' are required to achieve optimal shape fidelity and to improve the accuracy 
of 3D printed constructs. Therefore, the most important requirement of this material is the 
ability to be removed easily after the printing procedure. In addition, extra materials must be 
printable under similar conditions to other materials and they should be biocompatible. Because 
of these special properties, there are only a limited number of sacrificial materials available to 






Table 3: Overview of the printable sacrificial materials used for auricular cartilage 
regeneration 
Material Scaffold design Sacrificial procedure Reference 




PVA Ear shape 
Sacrificed with aqueous 
solution 
[75] 
 PEG Ear shape 
Sacrificed with distilled water 
or cell culture media 
[73, 74] 
 
PVA= Poly (vinyl alcohol); PEG= Poly (ethylene-glycol) 
 
 
Pluronics ® (Lutrol F127) are a class of commercially available thermosensitive hydrogels that 
have been widely reported as delivery systems for drugs and proteins [76]. These triblock 
copolymers of PEO-PPO-PEO (poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene 
oxide)) can exhibit gel-like behaviour at concentrations between 15-30% w/w, and is a 
reversible process that depends on physiological temperature, pH and the critical micellar 
concentration (CMC) [77]. One major drawback is the rapid dissolution of Pluronics in aqueous 
medium, thus limiting its use in long-term drug release or tissue encapsulation applications [78, 
79]. This drawback in drug delivery however, is advantageous when considering it as a 
sacrificial support material for bioprinting. Kang et al. [72], used Pluronic F-127 as sacrificial 
support for the cell-laden hydrogel mixture to guarantee the printed ear shape prior to 
crosslinking. Afterwards, the un-crosslinked Pluronic F-127 was easily washed out with 
water[72]. 
 
Poly (vinyl alcohol) (PVA) is a water-soluble synthetic polymer with high swelling properties. 
It can also be easily degraded by biological organisms through hydrolysis of its hydroxyl 
groups on the carbon backbone [80]. The complete decomposition of PVA in water can be 
achieved by immersing it in ~100°C for 30 minutes. Visser et al. [75], printed the anatomical 
structure of the human ear based on PCL with PVA as a support. The PVA was easily sacrificed 
through washing in hot water without compromising the quality of the target structure [75]. 
 
Poly(ethylene-glycol) (PEG) is a water soluble polyether that is non-immunogenic, non-toxic 
and possess useful properties such as protein and cellular resistivity [81]. PEG was used as 
sacrificial material to support the fabrication of ear scaffolds in the work conducted by Lee et 
al. [73, 74]. PCL and PEG polymers were deposited layer-by-layer into a porous framework 
and the PEG components were easily removed with distilled water or cell culture media once 
printing was completed [73, 74]. 
 
4.2.2 Structural framework 
To ensure the integrity of the scaffold after printing, polymers with sufficient mechanical 
strength can be incorporated into the design, herein referred to as the “structural framework”. 
When printed alongside other bio-inks, these materials can give rise to the overall rigidity of 
the scaffold, thereby improving the ease of handling for surgeons during implantation and help 
to maintain shape fidelity in post printing cleaning stages. In the case of hybrid printing, the 
presence of a structural framework within a scaffold design can provide temporary support for 
the weaker hydrogels and maintain their shape before crosslinking [82]. In the long run, this 
framework also protects the cell laden hydrogels from external forces to give time for cells to 
proliferate, differentiate and mature over time, such as skin contractions during healing in 
auricular cartilage reconstruction[71, 72, 74]. 
 
A list of printable polymers used as structural frameworks in scaffolds for auricular cartilage 
regeneration is listed in Table 4. Polylactic acid (PLA) is an organic biodegradable polyester, 
which is biocompatible and immunologically inert. Additionally, PLA has a melting 
temperature of 170 - 180 °C and is easy printable, making it interesting for 3D printing 
methods[83]. 
 
Polycaprolactone is a Food and Drug Administration (FDA) approved bioresorbable polyester 
and is used for medical advices since the 1980s [84]. It is one of the most commonly 
investigated biocompatible polymers for 3D printing because of the low melting point of 60°C 
and a slow degradation time (~1.5 to 2 years) [85, 86]. The low melting temperature enables 
PCL to be printed easily and in hybrid printing- alongside cell-laden hydrogels [87]. In addition, 
the synthetic polymer is well-known for excellent cell attachment, cell proliferation and a rapid 
cooling after extrusion, which minimises cell damage from heat transfer and provides long-
term structural stability [72, 88-91].  
 
PCL framework as support for the mechanical strength of a scaffold is one of the most 
commonly seen applications for 3D-printed biomaterials. Visser et al. [75], printed a uniform 
PCL scaffold in the shape of an outer ear with an auger screw driven melt extruder. This 
fabrication method showed promising results in the shape resolution of the print with overhangs 
and pertinent human dimensions [75]. Many research groups support their hybrid scaffolds 
with the synthetic material, which allows control of the mechanical properties and provides the 
shape [69, 72]. An alternate approach to use PCL as structural support in a scaffold was to 
design a cage-like structure surrounding the cell-laden hydrogel [82]. The cage was designed 
to prevent the cell-laden hydrogel from in vitro scaffold contraction while the tissue matures. 
This study showed that the framework maintains the shape during maturation and is a 
promising technique to withstand contractions and deformations [82].  
 











PCL Ear shape 
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PCL= Polycaprolactone; PLA= Polylactic acid; d = strand spacing; f = filament width 
 
4.2.3 Cell supporting material 
For the encapsulation of cells in a hydrogel, natural polymers (biopolymers) such as collagen, 
gelatin, alginate or fibrin are generally more suitable than synthetic polymers (Table 5). 
Hydrogels are known for their high-water retention, which protects the cells from drying during 
the printing process. Biopolymers interact positively with cells and have high biocompatibility 
but are limited by low stiffness and strength [93-95]. The hydrogel can provide the required 
environment for the cells to maintain their migration, production of extracellular molecules and 
proliferation[64]. 
 
Hyaluronic acid (HA) is a natural polymer often used for cartilage regeneration. HA is an 
anionic, non-sulphated glycosaminoglycan (GAG) and is one of the main components of the 
ECM in the body. It is well -known as a support material for cells to facilitate cell adhesion, 
migration and proliferation [96, 97]. The weak mechanical properties and viscous nature 
however, require HA to be blended with other hydrogels or chemically modified (attachment 
of a methacrylate group) so that it can be photo-crosslinked to provide stability after printing 
[98].  
 
Collagens constitutes a family of proteins present in the ECM of connective tissues. It 
comprises of three polypeptide chains that form a triple-helix structure and arranged in fibrils 
found in tissues such as tendon, bone, cartilage and skin [99]. Type II collagen is the 
predominant protein found in elastic cartilage with a small amount of type I collagen. Collagen 
is easily degraded and resorbed by the body and allows good attachment to cells. However, its 
mechanical properties are very low making it difficult to stack vertically when 3D printed and 
the rapid resorption by the body can affect the scaffold stability and maturation [100]. 
 
Fibrin is a protein, which is part of the clotting process in blood. Fibrin hydrogels seeded with 
chondrocytes can increase the production of GAG, which influences the production of ECM. 
Kang et al. [72], used a mixture of fibrinogen, gelatin, HA and glycerol as chondrocytes-laden 
hydrogel for auricular cartilage regeneration. Fibrinogen was cross-linked with thrombin, 
which converts it to fibrin. The mixture of the hydrogel maintained the structure after printing 
without cross-linking because of its high viscosity. Additionally, the hydrogel protected the 
cells during the printing process and produced microchannels for nutrient diffusion after the 
sacrificial procedure [72]. Limitations for fibrin includes degrading prematurely prior to adding 
cell culture media. 
 
Gelatin is an irreversibly hydrolysed form of collagen and mostly extracted from bones or skins 
of animals. It is often used for 3D cell printing applications due to its similarity to the 
extracellular matrix. The low stiffness of gelatin is a disadvantage for many applications; 
however, it is possible to overcome these limitations with chemical modifications of the gelatin 
hydrogels, as well as for biological properties [101]. GelMA is gelatin functionalized with 
methacrylate groups, where the hydrogel can become chemically crosslinked through presence 
of ultraviolent radiation [102]. Melchels et al. [103], printed the bioink consisting of 5% w/w 
GelMA and equine chondrocytes and assessed their viability. The cell were unaffected by the 
printing process, showing with an overall viability of 90% after 14 days.  
 
Alginate is one of the most commonly used cell-laden hydrogels for 3D printed tissue 
constructs. However, many studies have limited the study to chondrocyte, as alginate does not 
have the necessary cell-adhesion motifs for cell-ECM interactions. Therefore, for adherent cell 
types, alginates are commonly modified with RGD containing peptides to promote adhesion 
and proliferation [104]. The anionic polysaccharide is commonly received from brown algae 
and is well known as a supportive material for cells in cartilage tissues. An alginate 
chondrocyte-laden hydrogel to repair cartilage defects of rabbit ear models was studied by Park 
et al. [69]. The 3D printed scaffolds with the cell-laden alginate hydrogel showed complete 
cartilage regeneration after 3 month of in vivo studies. In addition, the cell printed structures 
were completely integrated into the surrounded native auricular cartilage of the rabbits and 
formed round aggregates [69]. 
 
Lee and co-workers on the other hand, designed a large 3D printed ear construct using PCL as 
a structural framework and two different cell-laden hydrogels [74]. The study printed alginate 
encapsulated with human auricular chondrocytes, and porcine ear cartilage-derived 
decellularised extracellular matrix (ear-cdECM) onto the pores of the framework. After 8 
weeks, they were able to show that the cells underwent chondrogenesis and were not affected 
by the long printing process with the hybrid printing approach [74]. The study by Kundu et al. 
[105] went even further and used a synthetic framework with three different compositions of 
the alginate hydrogel (I - alginate hydrogel without chondrocytes; II - alginate with 
chondrocytes; and III - cell-laden hydrogel with TGF-β as a growth factor). The combination 
of a cell-laden hydrogel with a growth factor showed promising results for applications in 
auricular cartilage regeneration [105]. 
 
Table 1: Overview of the printable cell supporting materials used for auricular cartilage 
regeneration 
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4.3 Cell sources 
4.3.1 Primary Chondrocytes 
Auricular cartilage is a type of elastic cartilage that is composed predominantly of ECM with 
relatively few cells. The distinction between elastic cartilage and the other subtypes; hyaline 
and fibrocartilage, is in the collagen, elastic fibre and tissue morphology [28].The tissue itself 
has a very slow turnover at cellular and molecular level, so there is limited capacity for self-
renewal and repair. Considerable success has been accomplished in a bio-engineered ear 
cartilage using isolated chondrocytes [33, 109, 110]. Primary chondrocytes isolated from 
human or animal sources can be mixed within hydrogel matrices to create “bio-inks” suitable 
for printing [105, 111]. One major drawback in obtaining the initial seeding density of primary 
chondrocytes is that they can de-differentiate upon multiple expansions to fibroblast, thus are 
unable to generate appropriate matrix the same way as normal cartilage. Furthermore, as a 
consequence of the de-differentiation process, it switches from collagen type II synthesis to 
collagen type I. Most studies do not recommend chondrocytes to be used after the third passage. 
This leads to difficulty in expanding chondrocytes in vitro and limiting its use [112]. Acquiring 
large amounts of human cartilage to expand and stimulate is also not practical, due to limitation 
in availability and morbidity of donor sites in the body [7]. Therefore, there is a need to search 
for alternate chondrogenic cell sources and culture methods to minimise the number of 
chondrocytes needed.  
 
4.3.2 Mesenchymal Stem cells 
A promising cell source in the field of cartilage repair is the mesenchymal stem cells (MSC). 
MSCs are adult stem cells that have the potential to differentiate into tissues including bone, 
fat or cartilage [113]. They can be isolated from various human tissues, including bone marrow, 
umbilical cord, and adipose tissue. MSCs hold great promise in the field of cartilage 
regeneration due to their chondrogenic differentiation capability and their non-immunogenic 
nature [114, 115]. This key characteristic of MSCs, where they express low to intermediate 
levels of human leukocyte antigen (HLA) class I and are negative for cell surface expression 
of HLA class II molecules,  makes them suitable for allogeneic therapy [116]. Interestingly, 
chondrocytes, adipocytes and osteocytes differentiated from human MSCs were also shown to 
be non-immunogenic in nature [112, 116]. Furthermore, the initial cell numbers required to 
culture and straightforward in vitro expansion protocols are an attractive cell source for tissue 
engineering. These all indicated that MSCs could be used as off-shelf product for allogeneic 
application for cartilage repair.   
More recently, there are emerging studies suggesting the benefits of using co-cultures of 
chondrocytes and MSCs in cartilage regeneration. Studies have shown that co-culturing not 
only leads to increased chondrogenic gene expressions and ECM deposition [117-119], but 
could also solve the problem of hypertrophy and calcification in MSCs due to extensive 
chondrogenic induction [120-122]. A study by Meretoja et al. [120] also found that the trophic 
effect of MSCs may increase the chondrogenic potentials of chondrocytes, thus reducing 
problems associated with primary chondrocyte harvesting and expansion. The exact molecular 
mechanism resulting in the stimulatory effect on the production of cartilage-like ECM when 
both cell types are co-cultured are yet to be fully understood. But there are studies suggesting 
that soluble factors such as transforming growth factor-β (TGF-β2), insulin-like growth factors 
(IGF-1), and bone morphogenetic protein (BMP-2), secreted by chondrocytes provide the 
initial chondrogenic signals [117, 123], while other studies demonstrated that cartilage specific 
matrices produced by chondrocytes are the key in differentiation of MSCs [124, 125]. One 
thing for certain is the synergistic effect between MSC and chondrocytes, where MSCs induce 
chondrocyte proliferation and chondrocytes stimulate MSC chondrogenesis, thus eliminating 
the need for constant stimulation of MSCs by growth factors into chondrocytes.  
4.3.3 Chondroprogenitor 
Chondroprogenitor cells or cartilage stem/progenitors cells in the perichondral layer of the 
auricular cartilage may serve as an alternate source of cells for elastic cartilage reconstruction 
[126]. Progenitor cells are very similar to stem cells and have the ability to differentiate into a 
specific cell type. However, they are more specific than a stem cell and are only able to 
differentiate into its target cell-type. These cartilage progenitor cells have been identified to 
have the ability to differentiate into elastic cartilage, but also to regenerate both the 
perichondrium and chondrium layers, which may be beneficial for long term stability of any 
implant [126, 127].  
The advantage of using autologous auricular progenitor cells as compared to harvesting 
primary chondrocytes is that it is a minimally invasive procedure that can be obtained from a 
thin fibrous layer of the auricle, even from microtia patients. From the perichondrial tissue, 
they can be isolated, cultured and guided TGF-β2 and IGF-1 [128]. The chondrogenic potential 
in these types of cells are also found to be age related with younger donors demonstrating five 
times higher in glycosaminoglycan (GAG) synthesis and collagen type II formation than older 
donors [113, 128]. In addition, they are highly proliferative and can therefore shorten the in 
vitro culture period [129]. Reports of using perichondrial grafts with different biomaterials to 
enhance chondrogenesis have also been investigated. Collagen sponge wrapped in 
perichondrium implanted into rabbit models after 7 weeks showed accelerated cartilage 
formation than materials containing perichondrium alone [130]. This was also the case when 
ear perichondrium was wrapped around a piece of demineralised bone matrix and implanted 
[131]. These results indicated that not only the cartilage progenitor cells could produce 
collagenous components, but are also able to maintain a non-calcified phenotype in the 
reconstructed cartilage. They represent a promising cell source for cartilage regeneration but 
longer in vivo studies are required. 
 
5. Conclusion 
The best surgical treatment for microtia, either autologous, alloplastic or prosthetic for 
auricular reconstruction is determined by various factors. These are mainly patient related 
factors (age, medication, and allergies), pathology of the residual ear, existing scars, and 
condition of surrounding tissue. The decision of whether the patient should undergo 
reconstruction via the autologous or alloplastic option also depends on the surgeon's experience 
and expertise. One of the limitations in traditional alloplastic frameworks is to accommodate 
individual patient’s reconstructive needs. Autologous reconstruction was better in this aspect 
in that there is no size or shape limitations as this can be modified during surgery, but comes 
with various degrees of complications. The use of prosthetics are also reserved for special cases 
and usually considered when the previous two options have failed. 
The combination of tissue engineering and additive manufacturing represents a new era to 
create custom-made tissue engineering solution to reconstructive surgery, which is heavily 
reliant on donor grafts and synthetic biomaterials. Compared to other organs, the cartilage is 
less complicated because of its avascular, aneural and alymphatic nature due to the dense ECM. 
Nevertheless, the combination of biomaterials, cells and biofabrication techniques to mimic the 
human ear still requires careful selection of appropriate structural, sacrificial, cell supporting 
materials and cell source. The choice between chondrocytes, stem cells, chondroprogenitor 
cells or co-culturing of cells, can all influence the final tissue morphology and composition as 
it matures over time.  
 
6. Current challenges and future trend 
Cartilage tissue engineering through bioprinting provided an alternative to currently used 
techniques that suffer from various limitations, but auricular cartilage regeneration is still at its 
infancy [132]. Longer in vivo and in vitro evaluation and efficacy studies are required. In 
addition, an ongoing aspect of bioprinting is stem cell harvesting and culturing for use in 
bioinks. Without an economically viable, efficient and reproducible method, bioprinting for 
cartilage regeneration cannot progress onto clinical trials. The use of pre-differentiated stem 
cells still meant that it requires at least 4-6 weeks of culture in vitro and for autologous 
procedures, the speed of cell processing is critical and requires more attention. Bioreactors may 
provide a vital role in maturation during in vitro culture, as reports have shown that the use of 
bioreactors speeds up the tissue maturation process and distribute nutrients uniformly across 
the scaffold. This resulted in better deposition of ECM [133]. 
Although auricular reconstruction is an aesthetic practice that requires a customised approach, 
the ongoing challenge is also in the performance and integration of the scaffold longer term. 
Bioprinting has already simplified the solution to fabricate an exact replica of the contralateral 
ear cartilage and the challenge now is to provide the required internal architecture or biological 
cues to better mimic the native cartilage and allow integration/vascularisation [134]. Studies 
now are leaning towards depositing multiple tissue types or materials into a single construct, 
as well as using multiple fabrication techniques to produce the scaffold [135, 136]. The use of 
chondrocytes alone cannot provide the sufficient cell numbers for a full size scaffold and more 
focus is on the use of MSC or adipose stem cell (ADSC) as they offer larger number of cells 
with high chondrogenic potential and readily accessible. Another challenge is to regenerate not 
just the cartilage but the skin and earlobe, which consist of fat cells. Cartilage and fat tissue 
induced simultaneously through co-culture has been shown possible by studies conducted by 
Lee et al. [137] and can fully utilise the capability of biofabrication technology. In addition, as 
the direction is heading towards better and more precise deposition of biological materials, 
laser based bioprinting techniques such as laser induced forward transfer (LIFT) offer several 
advantages over inkjet and extrusion based printing systems. The spot size resolution is close 
to the inkjet resolution of 40-100 µm and the printing speed is faster than extrusion. Since this 
method is nozzle-free, the viscosity (1-300 mPa/s) and cell density (1×108 cells/ml) achievable 
by this technique are much higher than inkjet [138]. However, a viscous material also suggests 
that cell distribution may not be uniform and the side effects of extended or intense laser 
exposure on the cell are yet to be well understood [139]. Further studies into the complementary 
use of different fabrication techniques, such as melt electro writing (MEW) [136, 140], inkjet, 
laser and extrusion based printing systems may open new doors where the scaffold itself can 
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